Want to join the conversation?
$CHS said its BoD has approved a new $300MM share buyback authorization and canceled the remainder of its Dec. 2013 share repurchase program. During FY15, $CHS has repurchased 14.6MM shares. $CHS said its Board declared a cash dividend of $0.0775 per share, a 3.3% up from Dec. 2014, payable Dec. 21, 2015 to shareholders of record on Dec. 7, 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.